Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-03-28 Purchase | 2025-04-01 6:44 pm | Perspective Therapeutics Inc. | CATX | Spoor Johan M. Chief Executive Officer | 26,676 | $2.2369 | $59,673 | 87,683 (Indirect Direct) | View |
2025-03-28 Purchase | 2025-04-01 5:04 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 60,337 | $2.1902 | $132,151 | 109,348 (Indirect Direct) | View |
2025-03-28 Purchase | 2025-04-01 5:03 pm | Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer | 33,333 | $2.2484 | $74,946 | 35,354 (Direct) | View |
2025-03-31 Purchase | 2025-04-01 5:03 pm | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 23,475 | $2.1299 | $49,999 | 188,267 (Indirect Direct) | View |
2024-12-04 Purchase | 2024-12-06 4:05 pm | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 25,975 | $3.85 | $100,004 | 25,975 (Indirect) | View |
2024-12-04 Purchase | 2024-12-04 5:20 pm | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 8,000 | $3.7665 | $30,132 | 55,257 (Indirect Direct) | View |
2024-11-25 Purchase | 2024-11-27 07:05 am | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 6,266 | $3.6408 | $22,814 | 433,721 (Indirect Direct) | View |
2024-11-25 Purchase | 2024-11-27 07:00 am | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 12,829 | $3.8175 | $48,974 | 48,800 (Direct) | View |
2024-11-25 Purchase | 2024-11-26 07:00 am | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 26,500 | $3.7912 | $100,468 | 228,672 (Indirect Direct) | View |
2024-06-17 Purchase | 2024-06-18 07:48 am | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 1,800 | $9.815 | $17,667 | 35,971 (Direct) | View |
2024-06-14 Purchase | 2024-06-18 07:45 am | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 4,587 | $10.9 | $49,990 | 164,792 (Indirect Direct) | View |
2024-06-13 Purchase | 2024-06-13 5:19 pm | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 100,000 | $1.1743 | $117,430 | 207,572 (Indirect Direct) | View |
2024-06-03 Purchase | 2024-06-04 4:02 pm | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 34,246 | $1.4598 | $49,992 | 1,553,984 (Indirect) | View |
2024-05-31 Purchase | 2024-06-03 4:05 pm | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 25,006 | $1.3999 | $35,007 | 341,716 (Direct) | View |
2024-05-31 Purchase | 2024-06-03 4:01 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 55,000 | $1.38 | $75,900 | 427,455 (Indirect Direct) | View |
2024-05-29 Purchase | 2024-05-30 4:05 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 30,031 | $1.3324 | $40,014 | 372,455 (Indirect Direct) | View |
2024-03-06 Purchase | 2024-03-08 11:24 am | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 60,431,039 | $0.95 | $57,409,487 | 116,773,394 (Direct) | View |
2024-01-30 Purchase | 2024-02-01 4:53 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 127,206 | $0.7131 | $90,710 | 342,424 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-03-03 Option Award | 2025-03-05 4:29 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 165,000 | $0 | 165,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:28 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Accounting Officer | 75,000 | $0 | 75,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:27 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Spoor Johan M. Chief Executive Officer | 650,000 | $0 | 650,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:25 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 50,000 | $0 | 50,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:22 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 50,000 | $0 | 50,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:20 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Morich Frank Director | 50,000 | $0 | 50,000 (Direct) | View |
2025-03-03 Option Award | 2025-03-05 4:18 pm | N/A 2035-03-03 | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 50,000 | $0 | 50,000 (Direct) | View |
2025-01-06 Option Award | 2025-01-07 4:50 pm | N/A 2035-01-06 | Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2025-01-07 4:48 pm | N/A N/A | Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer | 0 | $0 | 2,021 (Direct) | View |
2024-07-17 Option Award | 2024-07-19 07:36 am | N/A 2034-07-17 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 34,500 | $0 | 34,500 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:19 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 23,000 | $0 | 23,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:15 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Morich Frank Director | 23,000 | $0 | 23,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:13 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 23,000 | $0 | 23,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:11 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 23,000 | $0 | 23,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:09 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 500,000 | $0 | 500,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:07 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:05 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A N/A | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0.36 | 204,030 (Direct) | View |
2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A 2032-08-09 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0 | 204,030 (Direct) | View |
Ownership | 2024-02-01 07:56 am | N/A N/A | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 0 | $0 | 56,342,355 (Direct) | View |